St Charles Borromee, Canada Clinical Trials

A listing of St Charles Borromee, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

CAN003
 (0.8 away) Contact site
  • 0 views
  • 18 Jul, 2021
  • +253 other locations
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

Primary Objective: To demonstrate the efficacy of dupilumab in adult and adolescent participants with primary acquired chronic inducible cold urticaria (ColdU) who remain symptomatic despite the use of an H1-antihistamine Secondary Objectives: To demonstrate the efficacy of dupilumab on primary acquired chronic inducible ColdU disease control To demonstrate the efficacy …

Investigational Site Number :1240005
 (0.8 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +30 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in COPD participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 57 weeks, consisting of 2 …

muscarinic antagonists
copd exacerbation
albuterol
corticosteroids
cigarette smoke
GSK Investigational Site
 (0.8 away) Contact site
  • 379 views
  • 24 Jul, 2021
  • +232 other locations
Tezepelumab COPD Exacerbation Study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

copd exacerbation
severe chronic obstructive pulmonary disease
bronchodilator
ct scan
Research Site
 (0.8 away) Contact site
  • 130 views
  • 23 Jul, 2021
  • +107 other locations
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity and safety profile. The Phase 3 portion is an event-driven, randomized, observer blinded, placebo-controlled design that will evaluate the efficacy and safety of the CoVLP formulation compared …

Diex Recherche Joliette
 (0.8 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +73 other locations
A Research Study to Compare a New Weekly Insulin Insulin Icodec Used With DoseGuide App and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

This study compares insulin icodec to different daily insulins in people with type 2 diabetes. The study will look at how well insulin icodec taken once weekly controls blood sugar compared to the insulins taken once daily. Participants will either get insulin icodec, that participants will have to inject once …

Novo Nordisk Investigational Site
 (0.8 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +154 other locations
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients

The purpose of this study is to support the dose selection for future studies by evaluating efficacy and safety of different QBW251 doses in COPD patients with chronic bronchitis and a history of exacerbations, compared to placebo, when added to a triple combination therapy of LABA, LAMA and ICS with …

bronchitis
Novartis Investigative Site
 (0.8 away) Contact site
  • 176 views
  • 26 Jul, 2021
  • +173 other locations